Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic prescriptions.

In 2024, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs. The CDER director, Patrizia ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Shares of up-and-coming weight loss drug developers Viking Therapeutics (NASDAQ:VKTX), Metsera (NASDAQ:MTSR), and Structure ...

Pfizer (PFE) stock was up on Monday despite the pharmaceutical company ending the clinical trial of its once-daily GLP-1 ...

Weight loss pills are generally safe when taken under proper medical supervision with awareness of potential side effects.

“We continue to think investors will be best served in longer-duration bonds and capturing the high yield carry along with potential future price appreciation, as our US economics team forecasts ...

However, not all OTC weight loss supplements are created equal, and some may be ineffective or even harmful. When choosing the best OTC weight loss supplement, it’s essential to pay attention to ...

KEEP ALL YOUR SUPPLEMENTS IN ONE CONTAINER Organize all your medications or supplements in this one convenient pill dispenser - no more opening several bottles when it's time to take your pills!

"This difference could affect weight, cholesterol levels and blood sugar levels – all of which can affect your risk of heart and circulatory diseases." The British Heart Foundation has suggested ...